Check out our most popular compounded medications! Get Started
This Buprenorphine 0.4 mg troche is a square-shaped solid dosage form that dissolves slowly in the mouth. It delivers medication through oral mucosa absorption for targeted local or systemic effects. It is used to treat opioid dependence, chronic pain, severe pain, cancer pain, and neuropathic pain.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Buprenorphine 0.4 mg Troche is a specialized medication primarily used for the treatment of opioid dependence, chronic pain, severe pain, cancer pain, and neuropathic pain. This unique formulation is a square-shaped solid dosage form that is designed to dissolve slowly in the mouth. The medication is delivered through the absorption of the oral mucosa, targeting local or systemic effects as needed.
This long-acting, sublingual medication is specifically designed to provide sustained relief from pain and symptoms of opioid dependence. Furthermore, it is also beneficial in managing chronic pain, severe pain, cancer pain, and neuropathic pain, as it assists in reducing pain intensity and enhancing the quality of life of patients.
At Bayview Pharmacy, we are committed to providing this compounded formulation of Buprenorphine 0.4 mg Troche to our patients. Our compounding pharmacist is well-versed and ready to answer any questions you may have about this medication and its usage. We encourage you to reach out to us if you have any queries or need further information about this medication.
This Buprenorphine 0.4 mg Troche formulation is a square-shaped solid dosage form designed to dissolve slowly in the mouth. It delivers medication through oral mucosa absorption for targeted local or systemic effects. It is primarily used in the treatment of opioid dependence, chronic pain, severe pain, cancer pain, and neuropathic pain. However, it is not recommended for use in patients with acute pain, as it is not designed to treat such conditions.
It is crucial to monitor patients closely for signs of abuse or misuse, as buprenorphine has the potential to be habit-forming. Additionally, patients should be observed for signs of respiratory depression, as buprenorphine can cause this condition when taken in high doses or when combined with other CNS depressants.
Patients should also be monitored for signs of withdrawal, as buprenorphine can cause withdrawal symptoms when discontinued abruptly. Furthermore, patients should be observed for signs of sedation, as buprenorphine can cause sedation when taken in high doses or when combined with other CNS depressants.
If you have any questions about this formulation or its interactions, please do not hesitate to reach out for further information. It is always important to use this medication under the supervision of a healthcare professional to ensure its safe and appropriate use.
Buprenorphine 0.4 mg Troche is a potent medication primarily used for the treatment of various pain conditions and opioid dependence. It is a long-acting opioid agonist, which means it binds to and activates opioid receptors in the brain, providing relief from pain and other symptoms. This medication is designed to be taken orally, typically once a day, and is absorbed through the oral mucosa.
One of the primary uses of Buprenorphine 0.4 mg Troche is in the treatment of opioid dependence. It aids in reducing cravings and withdrawal symptoms by activating the opioid receptors in the brain. However, it's crucial to understand that buprenorphine is not a standalone cure for opioid dependence. It should be used as part of a comprehensive treatment plan that may include counseling and lifestyle modifications.
It provides relief by activating the opioid receptors in the brain. However, it's important to note that buprenorphine is not a cure for these pain conditions. It should be used in conjunction with other treatments such as physical therapy and lifestyle changes.
As a long-acting opioid agonist, Buprenorphine 0.4 mg Troche should be taken exactly as prescribed by a healthcare provider. It's crucial to follow the instructions on the prescription label and not to exceed the prescribed dosage. Keeping track of the amount of medication taken is also important to avoid misuse.
If you have any questions about Buprenorphine 0.4 mg Troche or its role in treating opioid dependence or various pain conditions, please don't hesitate to reach out. We are here to provide the necessary information and support.
Buprenorphine 0.4 mg Troche is a square-shaped solid dosage form that is designed to dissolve slowly in the mouth. This unique formulation allows for the medication to be absorbed through the oral mucosa, providing targeted local or systemic effects. It is primarily used in the treatment of opioid withdrawal symptoms, which can include nausea, vomiting, and diarrhea. This medication can also help to reduce cravings for opioids, thereby aiding in the prevention of relapse.
In addition to its use in opioid withdrawal, Buprenorphine 0.4 mg Troche can also be utilized for the management of severe pain. This includes pain associated with conditions such as fibromyalgia, rheumatoid arthritis, and multiple sclerosis.
Furthermore, Buprenorphine 0.4 mg Troche can be used in the treatment of cancer pain. This type of pain can be caused by the cancer itself or by the treatments used to combat it. If you have any questions about the use of Buprenorphine 0.4 mg Troche for any of these conditions, please do not hesitate to reach out for more information.
A Buprenorphine 0.4 mg Troche is a square-shaped solid dosage form of the medication Buprenorphine. It is designed to dissolve slowly in the mouth and deliver medication through absorption by the oral mucosa for targeted local or systemic effects.
The Buprenorphine 0.4 mg Troche works by dissolving slowly in the mouth. The medication is then absorbed through the oral mucosa, which allows for targeted local or systemic effects.
You should place the Buprenorphine 0.4 mg Troche in your mouth and allow it to dissolve slowly. Do not chew or swallow the troche as it is designed to be absorbed through the oral mucosa.
Taking Buprenorphine in a troche form allows for the medication to be absorbed directly through the oral mucosa. This can provide targeted local or systemic effects and may result in a faster onset of action compared to other dosage forms.
If you accidentally swallow a Buprenorphine 0.4 mg Troche, contact your healthcare provider immediately. The troche is designed to be absorbed through the oral mucosa, not the digestive system.
No, you should not cut or break a Buprenorphine 0.4 mg Troche. It is designed to dissolve slowly in the mouth for optimal absorption through the oral mucosa.
If you miss a dose of Buprenorphine 0.4 mg Troche, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
It is recommended to avoid eating or drinking while the Buprenorphine 0.4 mg Troche is in your mouth. This can interfere with the absorption of the medication through the oral mucosa.
Side effects of Buprenorphine 0.4 mg Troche can include nausea, vomiting, constipation, lightheadedness, dizziness, drowsiness, and sweating. If any of these effects persist or worsen, contact your healthcare provider immediately.
If you are pregnant or breastfeeding, you should consult with your healthcare provider before taking Buprenorphine 0.4 mg Troche. The medication can pass into breast milk and may have undesirable effects on a nursing infant.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
